Ayurveda wellness brand Kapiva has raised USD 60 million in a Series D funding round led by 360 ONE Asset and Vertex Growth, with continued support from existing investors including Vertex Ventures Southeast Asia & India and 3one4 Capital. Of the total funding, USD 28 million represents fresh capital, while the remainder facilitated secondary transactions, enabling partial exits for some of the brand’s early backers.
The newly raised funds will be strategically utilized across multiple areas of the business. Kapiva plans to strengthen its research and development initiatives, expand manufacturing capabilities, and ramp up brand-building and marketing efforts to deepen consumer trust and awareness. Additionally, a significant portion of the investment will go towards enhancing the company’s health-tech ecosystem, integrating technology with Ayurveda to provide consumers with personalized wellness solutions.
Currently, Kapiva is operating at an impressive annual revenue run rate of approximately ₹550 crore, reflecting a compounded annual growth rate (CAGR) of over 80% year-on-year over the past few years. This rapid growth highlights both the increasing acceptance of Ayurveda-based wellness solutions and the company’s ability to scale effectively. The brand already has a strong footprint in offline retail, with presence in nearly 40,000 stores across India, while also expanding aggressively across digital platforms and pharmacy networks.
Founded by Ameve Sharma and Shrey Badhani, Kapiva has established itself as a leading modern Ayurveda brand. Its product portfolio spans multiple categories, including sports nutrition, daily wellness, hormonal balance, liver care, and chronic health management. By blending traditional Ayurvedic knowledge with modern health needs, the company has carved a niche for itself in India’s rapidly evolving health and wellness market.
“Ayurveda wellness brand Kapiva has raised USD 60 million in a Series D funding round led by 360 ONE Asset and Vertex Growth, with participation from existing backers including Vertex Ventures Southeast Asia & India and 3one4 Capital. This round included USD 28 million in fresh capital, while the balance was used for secondary transactions to allow partial exits for early investors.”
With its strong growth momentum and fresh capital infusion, Kapiva is now positioned to scale operations aggressively, expand its health-tech offerings, and move closer to profitability. This funding milestone further cements Kapiva’s vision of making Ayurveda accessible, personalized, and relevant for modern consumers in India and beyond.
